M. D’Incan
Université Clermont Auvergne(FR)University of Clermont Auvergne(FR)Centre Hospitalier Universitaire de Clermont-Ferrand(FR)Centre Hospitalier Universitaire de Clermont-Ferrand(FR)
Publications by Year
Research Areas
Cutaneous lymphoproliferative disorders research, Autoimmune Bullous Skin Diseases, Urticaria and Related Conditions, Nail Diseases and Treatments, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid(2002)614 cited
- → First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial(2017)587 cited
- → Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial(2017)569 cited
- → A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma(2011)515 cited
- → A Single Cycle of Rituximab for the Treatment of Severe Pemphigus(2007)461 cited
- → EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome(2006)416 cited